Mountain View, CA, United States of America

David G King

USPTO Granted Patents = 17 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 134(Granted Patents)

Location History:

Carlsbad, CA (US) (2016 - 2017)
Mountain View, CA (US) (2015 - 2019)
San Francisco, CA (US) (2011 - 2020)

Company Filing History:

Life Technologies Corporation

patents

1 out of 15,458

University of California

patents

Years Active: 2011-2020

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10597705 - Enhanced ligation reactions (2020-03-24),

2. 10494671 - Enzymatic ligation of nucleic acids (2019-12-03),

3. 10303781 - Deriving associations between assets (2019-05-28),

4. 10093969 - Enhanced ligation reactions (2018-10-09),

5. 9765388 - Enhanced ligation reactions (2017-09-19),

6. 9652458 - Deriving associations between assets (2017-05-16),

7. 9633014 - Policy based video content syndication (2017-04-25),

8. 9396312 - Syndication including melody recognition and opt out (2016-07-19),

9. 9315861 - Enhanced ligation reactions (2016-04-19),

10. 9142000 - Media rights management using melody identification (2015-09-22),

11. 9129094 - Syndication including melody recognition and opt out (2015-09-08),

12. 9098807 - Video content claiming classifier (2015-08-04),

13. 9058329 - Deriving associations between assets (2015-06-16),

14. 8706675 - Video content claiming classifier (2014-04-22),

15. 8584198 - Syndication including melody recognition and opt out (2013-11-12),

Title: David G King: Innovator in Nucleic Acid Ligation

Introduction

David G King is a prominent inventor based in Mountain View, CA (US). He holds a total of 17 patents that showcase his contributions to the field of molecular biology, particularly in nucleic acid ligation techniques. His innovative work has significantly advanced the methodologies used in genetic research and biotechnology.

Latest Patents

Among his latest patents, King has developed methods for enhanced ligation reactions. These methods involve conducting nucleic acid ligation reactions in the presence of agents that generate ligatable terminal 5' phosphate groups. In some embodiments, an aprataxin enzyme is utilized to catalyze the removal of an adenylate group from a terminal 5' phosphate of a nucleic acid. Additionally, he has introduced methods, assays, compositions, and kits for the ligation of short polynucleotides, which can be as short as 3 or 4 nucleotides in length. The ligation process is optionally performed by CV ligase, showcasing his innovative approach to nucleic acid manipulation.

Career Highlights

David G King has had a distinguished career, working with notable companies such as Google Inc. and Life Technologies Corporation. His experience in these leading organizations has allowed him to refine his skills and contribute to groundbreaking advancements in biotechnology.

Collaborations

Throughout his career, King has collaborated with esteemed colleagues, including Stephen P Hendricks and Lei Xi. These partnerships have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

David G King is a remarkable inventor whose work in nucleic acid ligation has made a lasting impact on biotechnology. His numerous patents and collaborations reflect his dedication to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.